Skip to main content
Equibles

Jump Financial, LLC

Position in IMVT — Immunovant, Inc.

CIK 1831577 Chicago, IL
Back to IMVT Full portfolio

Position in IMVT

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$4,815,749
+$3,717,772 QoQ
Shares Held
124,987
+182.8% QoQ
Ownership
0.061%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#57
of 226 holders
Holding Since
Dec 2020
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in IMVT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Jump Financial, LLC holds $441,725,895 across 169 Biotechnology names. IMVT ranks #28 (1.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 IONS
Ionis Pharmaceuticals Inc
 306,330 $24,288,904
2 VKTX
Viking Therapeutics, Inc.
 579,882 $22,621,196
3 XENE
Xenon Pharmaceuticals Inc.
 260,730 $15,737,662
4 CRSP
CRISPR Therapeutics AG
 277,952 $15,159,500
5 BMRN
Biomarin Pharmaceutical Inc
 245,390 $14,041,214
6 SRPT
Sarepta Therapeutics, Inc.
 679,445 $12,209,626
7 REGN
Regeneron Pharmaceuticals, Inc.
 16,242 $10,127,536
8 RARE
Ultragenyx Pharmaceutical Inc.
 286,952 $9,581,327

All Filings in IMVT

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,815,749 124,987
2026-03-31 $1,097,977 44,202
2025-12-31 $2,658,981 104,602
2025-09-30 $4,775,711 296,260
2025-06-30 $5,165,536 322,846
2025-03-31 $3,432,269 200,835
2024-12-31 $3,211,875 129,668
2024-09-30 $1,749,259 61,356
2024-06-30 $3,998,860 151,472
2024-03-31 $3,069,450 95,000
2023-12-31 $1,224,803 29,072
2023-09-30 $461,678 12,026
2023-03-31 $707,256 45,600
2022-03-31 $103,037 18,700
2021-12-31 $621,108 72,900
2021-09-30 $639,584 73,600
2021-06-30 $1,469,599 139,035
2021-03-31 $361,926 22,564
2020-12-31 $383,377 8,300